The results of this study, which are based on dynamic monitoring of CSF cfDNA and IL-10 concentrations, are consistent with those of previous studies demonstrating IL-10 and cfDNA as biomarkers for PCNSL. Here, IL10 is linked to primary central nervous system lymphoma.